Skip to main content
Clinical Trials/ACTRN12610000192088
ACTRN12610000192088
Completed
N/A

In patients with osteoarthritis of the knee, are patient specific cutting guides used for total knee joint replacement as good as traditional instruments for patient outcomes?

Stryker Australia0 sites100 target enrollmentMarch 3, 2010

Overview

Phase
N/A
Intervention
Not specified
Conditions
Osteoarthritis of the knee
Sponsor
Stryker Australia
Enrollment
100
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 3, 2010
End Date
April 19, 2018
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Stryker Australia

Eligibility Criteria

Inclusion Criteria

  • 1\. The patient is a male or non\-pregnant female between the ages of 50\-90\.
  • 2\. The patient requires a primary total knee replacement and is indicated for computer\-assisted surgery.
  • 3\. The patient has a primary diagnosis of osteoarthritis (OA).
  • 4\. The patient has intact collateral ligaments.
  • 5\. The patient is able to undergo MRI scanning of the affected limb.
  • 6\. The patient has signed the study specific, Human Research Ethics Committee (HREC) approved, Informed Consent document.
  • 7\. The patient is willing and able to comply with the specified pre\-operative and post\-operative clinical and radiographic evaluations.

Exclusion Criteria

  • 1\. The patient has a history of total, unicompartmental reconstruction or fusion of the affected joint.
  • 2\. Patient has had a high tibial osteotomy or femoral osteotomy.
  • 3\. The patient is morbidly obese (Body Mass Index, BMI \= 40\).
  • 4\. The patient has a deformity which will require the use of stems, wedges or augments in conjunction with the Triathlon Total Knee System.
  • 5\. The patient has a varus/valgus malalignment \= 15 degrees.
  • 6\. The patient has a fixed flexion deformity \= 15 degrees.
  • 7\. The patient has a neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device.
  • 8\. The patient has a systemic or metabolic disorder leading to progressive bone deterioration.
  • 9\. The patient is immunologically suppressed or receiving steroids in excess of normal physiological requirements.
  • 10\. Patient has a cognitive impairment, an intellectual disability or a mental illness.

Outcomes

Primary Outcomes

Not specified

Similar Trials